Near vision blurriness begins
at age 40. Presbyopia or near vision blurriness is a natural part of aging
where individuals experience difficulty reading printed words up close,
checking websites onscreen or seeing objects at a distance.
Presbyopia can be corrected
with progressive lenses that provide seamless vision between near, intermediate
and far distances. Progressive lenses no longer have the distinct line found
across traditional bi-focals, giving the wearer a more modern, youthful
look.
Essilor, the inventor of
progressive lenses, presents the Varilux® X seriesTM,
designed to reinvent near vision by extending it further within arm’s reach.
“With
the launch of the
Varilux® X seriesTM, 40-year-olds and
above no longer have to worry about vision problems. They can enjoy life with
clear and healthy eye sight,” said Essilor Philippines general manager Dr.
Emelita Roleda.
The
most advanced progressive lens, the Varilux® X seriesTM uses a
revolutionary technology called Xtend™. The result is near vision
sharpness and fluidity within arm’s reach.
With today’s
digital-focused life, 40-something individuals can comfortably and seamlessly
capture every detail when viewing their smartphones, tablets and laptops.
.
See life clearly with the Varilux® X seriesTM progressive lenses.
Learn more about Varilux
progressive lenses by visiting your eye care professional or leading optical
shop by logging on to www.essilor.com.ph
About Essilor
The world's leading
ophthalmic optics company, Essilor designs, manufactures and markets a wide
range of lenses to improve and protect eyesight. Its mission is to improve
lives by improving sight. To support this mission, Essilor allocates more than
€200 million to research and innovation every year, in a commitment to
continuously bring new, more effective products to market. Its flagship brands
are Varilux®, Crizal®, Crizal Transitions®, Crizal Eyezen™, Xperio®, It also
develops and markets equipment, instruments and services for eye care
professionals.
Essilor reported
consolidated revenue of more than €7.1 billion in 2016 and employs 64,000
people worldwide. It markets its products in more than 100 countries and has 32
plants, 523 prescription laboratories and edging facilities, as well as five
research and development centres around the world. For more information, please
visit www.essilor.com.
The Essilor share
trades on the Euronext Paris market and is included in the Euro Stoxx 50 and
CAC 40 indices.
Comments
Post a Comment